INNOVUS PHARMACEUTICALS, INC.

New Filing
CIK: 0001411879·Pharmaceuticals·NEVADA·Filed: May 20, 2013
Total Offering

$450,000

Amount Sold

$450,000

Investors

1

First Sale

Apr 19, 2013

Offering Details

Type
Equity
Exemptions
Rule 506
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Bassam Damaj
Related Person

Company

INNOVUS PHARMACEUTICALS, INC.

4275 EXECUTIVE SQUARE, SUITE 200

LA JOLLA, CA, 92037

858-964-5123

SEC Filing

0001144204-13-030415

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
INNOVUS PHARMACEUTICALS, INC. Form D Filing — $450,000 | FilingFlow